AZNCF
Price
$134.98
Change
+$2.85 (+2.16%)
Updated
Jan 17 closing price
Capitalization
222.83B
MRK
Price
$97.92
Change
-$2.78 (-2.76%)
Updated
Jan 17 closing price
Capitalization
331.75B
16 days until earnings call
Ad is loading...

AZNCF vs MRK

Header iconAZNCF vs MRK Comparison
Open Charts AZNCF vs MRKBanner chart's image
AstraZeneca
Price$134.98
Change+$2.85 (+2.16%)
Volume$1.59K
Capitalization222.83B
Merck & Co
Price$97.92
Change-$2.78 (-2.76%)
Volume$16.18M
Capitalization331.75B
AZNCF vs MRK Comparison Chart
Loading...
AZNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZNCF vs. MRK commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZNCF is a Hold and MRK is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (AZNCF: $134.98 vs. MRK: $97.92)
Brand notoriety: AZNCF: Not notable vs. MRK: Notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZNCF: 52% vs. MRK: 140%
Market capitalization -- AZNCF: $222.83B vs. MRK: $331.75B
AZNCF [@Pharmaceuticals: Major] is valued at $222.83B. MRK’s [@Pharmaceuticals: Major] market capitalization is $331.75B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZNCF’s FA Score shows that 1 FA rating(s) are green whileMRK’s FA Score has 1 green FA rating(s).

  • AZNCF’s FA Score: 1 green, 4 red.
  • MRK’s FA Score: 1 green, 4 red.
According to our system of comparison, MRK is a better buy in the long-term than AZNCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZNCF’s TA Score shows that 4 TA indicator(s) are bullish while MRK’s TA Score has 4 bullish TA indicator(s).

  • AZNCF’s TA Score: 4 bullish, 1 bearish.
  • MRK’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, AZNCF is a better buy in the short-term than MRK.

Price Growth

AZNCF (@Pharmaceuticals: Major) experienced а -0.38% price change this week, while MRK (@Pharmaceuticals: Major) price change was -1.34% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.03%. For the same industry, the average monthly price growth was -0.28%, and the average quarterly price growth was -6.86%.

Reported Earning Dates

MRK is expected to report earnings on Apr 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.03% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRK($332B) has a higher market cap than AZNCF($223B). MRK has higher P/E ratio than AZNCF: MRK (935.64) vs AZNCF (36.10). AZNCF YTD gains are higher at: 3.831 vs. MRK (-1.568). AZNCF has higher annual earnings (EBITDA): 12.9B vs. MRK (6.91B). MRK has more cash in the bank: 7.09B vs. AZNCF (5.81B). AZNCF has less debt than MRK: AZNCF (29.8B) vs MRK (35.1B). MRK has higher revenues than AZNCF: MRK (60.1B) vs AZNCF (44.5B).
AZNCFMRKAZNCF / MRK
Capitalization223B332B67%
EBITDA12.9B6.91B187%
Gain YTD3.831-1.568-244%
P/E Ratio36.10935.644%
Revenue44.5B60.1B74%
Total Cash5.81B7.09B82%
Total Debt29.8B35.1B85%
FUNDAMENTALS RATINGS
AZNCF vs MRK: Fundamental Ratings
AZNCF
MRK
OUTLOOK RATING
1..100
509
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
17
Undervalued
PROFIT vs RISK RATING
1..100
4646
SMR RATING
1..100
5234
PRICE GROWTH RATING
1..100
5861
P/E GROWTH RATING
1..100
65100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRK's Valuation (17) in the Pharmaceuticals Major industry is in the same range as AZNCF (25) in the null industry. This means that MRK’s stock grew similarly to AZNCF’s over the last 12 months.

MRK's Profit vs Risk Rating (46) in the Pharmaceuticals Major industry is in the same range as AZNCF (46) in the null industry. This means that MRK’s stock grew similarly to AZNCF’s over the last 12 months.

MRK's SMR Rating (34) in the Pharmaceuticals Major industry is in the same range as AZNCF (52) in the null industry. This means that MRK’s stock grew similarly to AZNCF’s over the last 12 months.

AZNCF's Price Growth Rating (58) in the null industry is in the same range as MRK (61) in the Pharmaceuticals Major industry. This means that AZNCF’s stock grew similarly to MRK’s over the last 12 months.

AZNCF's P/E Growth Rating (65) in the null industry is somewhat better than the same rating for MRK (100) in the Pharmaceuticals Major industry. This means that AZNCF’s stock grew somewhat faster than MRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNCFMRK
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
57%
Bullish Trend 11 days ago
57%
Momentum
ODDS (%)
Bullish Trend 11 days ago
61%
Bullish Trend 11 days ago
54%
MACD
ODDS (%)
Bullish Trend 11 days ago
63%
Bullish Trend 11 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
62%
Bullish Trend 11 days ago
50%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
56%
Bearish Trend 11 days ago
43%
Advances
ODDS (%)
Bullish Trend 11 days ago
66%
Bullish Trend 12 days ago
47%
Declines
ODDS (%)
Bearish Trend 13 days ago
51%
Bearish Trend 16 days ago
50%
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
45%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
AZNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MMI36.630.47
+1.30%
Marcus & Millichap
IESC256.691.27
+0.50%
IES Holdings
VCIG1.30N/A
N/A
VCI Global Limited
WMB59.14-0.04
-0.07%
Williams Companies
TSHA1.53-0.05
-3.16%
Taysha Gene Therapies

AZNCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZNCF has been loosely correlated with AZN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AZNCF jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZNCF
1D Price
Change %
AZNCF100%
+2.16%
AZN - AZNCF
48%
Loosely correlated
-0.46%
NVS - AZNCF
24%
Poorly correlated
-0.34%
SNY - AZNCF
23%
Poorly correlated
N/A
MRK - AZNCF
19%
Poorly correlated
-2.76%
BAYRY - AZNCF
18%
Poorly correlated
+1.50%
More

MRK and

Correlation & Price change

A.I.dvisor tells us that MRK and AZN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MRK and AZN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
-2.76%
AZN - MRK
29%
Poorly correlated
-0.46%
GSK - MRK
23%
Poorly correlated
-0.03%
SNY - MRK
21%
Poorly correlated
N/A
BIIB - MRK
21%
Poorly correlated
-0.48%
SNYNF - MRK
20%
Poorly correlated
+1.43%
More